Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Q2 2023 Earnings Call Transcript August 3, 2023
Agios Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-1.51 EPS, expectations were $1.6.
Operator: Good morning, and welcome to Agios’ Second Quarter 2023 Conference Call. At this time, all participants are in a listen-only mode. There will be a question-and-answer session at the end. Please be advised that this call is being recorded at Agios’ request. I would now like to...
